Skip to main content

Advertisement

Log in

Association of TGF-β1 +869C/T promoter polymorphism with susceptibility to autoimmune diseases: a meta-analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Many case–control studies have investigated the role of TGF-β1 gene +869C/T promoter polymorphism in autoimmune diseases, but the results are inconsistent. To clarify this point, we performed a meta-analysis based on all available studies in Pubmed, Elsevier Science Direct, Google Searching, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure. Crude odds ratios (ORs) with 95 % confidence intervals were calculated to estimate the strength of the association. A fixed or random effects model was used on the basis of heterogeneity. A total of 21 papers including 2,693 cases and 3,036 controls were considered in the current meta-analysis. These studies encompass two ankylosing spondylitis (AS), eight rheumatoid arthritis (RA), four systemic lupus erythematosus (SLE), and seven systemic sclerosis (SSc). The results showed that TGF-β1 +869C/T promoter polymorphism were associated with susceptibility to RA (CC vs. TT: OR = 0.65, 95 % CI = 0.48–0.88, P = 0.005; CC vs. CT + TT: OR = 0.56, 95 % CI = 0.45–0.69, P = 0.000; C vs. T: OR = 0.81, 95 % CI = 0.71–0.93, P = 0.003). When stratified by race, significant association was observed only in Asian population. However, we failed to reveal the association between this gene promoter polymorphism and AS, SLE, and SSc. Therefore, this meta-analysis suggests a possible association between TGF-β1 +869C/T promoter polymorphism and RA, especially in Asian population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Marrack P, Kappler J, Kotzin BL (2001) Autoimmune disease: why and where it occurs. Nat Med 7:899–905

    Article  CAS  PubMed  Google Scholar 

  2. Wandstrat A, Wakeland E (2001) The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2:802–809

    Article  CAS  PubMed  Google Scholar 

  3. Becker KG (2004) The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62:309–317

    Article  CAS  PubMed  Google Scholar 

  4. Massague J (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6:597–641

    Article  CAS  PubMed  Google Scholar 

  5. Fujii D, Brissenden JE, Derynck R et al (1986) Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet 12(3):281–288

    Article  CAS  PubMed  Google Scholar 

  6. Aoki CA, Borchers AT, Li M et al (2005) Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmun Rev 4(7):450–459

    Article  CAS  PubMed  Google Scholar 

  7. Haukim N, Bidwell JL, Smith AJ et al (2002) Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 3(Suppl 2):313–330

    Article  CAS  PubMed  Google Scholar 

  8. Howe HS, Cheung PL, Kong KO et al (2005) Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis. Rheumatology (Oxford) 44(1):51–54

    Article  CAS  Google Scholar 

  9. van der Paardt M, Crusius JB, García-González MA et al (2005) Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms. Ann Rheum Dis 64(4):616–619

    Article  PubMed  Google Scholar 

  10. Alayli G, Kara N, Tander B et al (2009) Association of transforming growth factor β1 gene polymorphism with rheumatoid arthritis in a Turkish population. Jt Bone Spine 76:20–23

    Article  CAS  Google Scholar 

  11. Panoulas VF, Douglas KMJ, Smith JP et al (2009) Transforming growth factor-β1 869T/C, but not interleukin-6 174G/C, polymorphism associates with hypertension in rheumatoid arthritis. Rheumatology 48:113–118

    Article  CAS  PubMed  Google Scholar 

  12. Sugiura Y, Niimi T, Sato S et al (2002) Transforming growth factor beta 1 gene polymorphism in rheumatoid arthritis. Ann Rheum Dis 61:826–828

    Article  CAS  PubMed  Google Scholar 

  13. Pokorny V, Chau J, Wu L et al (2003) Transforming growth factor beta 1 gene (HSTGFB1) nucleotide T869C (codon10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a caucasian population. Ann Rheum Dis 62:907–908

    Article  CAS  PubMed  Google Scholar 

  14. Wang YP, Xiao LS, Zhou Y et al (2007) Gene polymorphisms of transforming growth factor-β1 with rheumatoid arthritis. Chin J Public Health 11:1405–1406

    Google Scholar 

  15. Zhu Y, Liu F, Zhang F et al (2006) Correlation of transforming growth factor-β1 T869C polymorphism and rheumatoid arthritis in Chinese population. Jiangsu Med J 32:1112–1114

    CAS  Google Scholar 

  16. Li YY (2011) To investigate relationship of the polymorphisms of TGF-β1 in patients with rheumatoid arthritis. Zhengzhou University

  17. Kim SY, Han SW, Kim GW et al (2004) TGF-beta1 polymorphism determines the progression of joint damage in rheumatoid arthritis. Scand J Rheumatol 33:389–394

    Article  CAS  PubMed  Google Scholar 

  18. Wang B, Morinobu A, Kanagawa S et al (2007) Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus. Kobe J Med Sci 53(1–2):15–23

    CAS  PubMed  Google Scholar 

  19. Guarnizo-Zuccardi P, Lopez Y, Giraldo M et al (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70(5):376–382

    Article  CAS  PubMed  Google Scholar 

  20. Lu LY, Cheng HH, Sung PK et al (2004) Single-nucleotide polymorphisms of transforming growth factor-beta 1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect 37(3):145–152

    CAS  PubMed  Google Scholar 

  21. Lu LY, Cheng HH, Sung PK et al (2005) Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan. J Formos Med Assoc 104(8):563–570

    CAS  PubMed  Google Scholar 

  22. Beretta L, Cappiello F, Moore JH et al (2008) Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Arthritis Rheum 59(7):974–983

    Article  CAS  PubMed  Google Scholar 

  23. Büyük U, Ates O, Dalyan L et al (2010) Analysis of transforming growth factor beta 1 (TGF-beta1) gene polymorphisms in Turkish patients with scleroderma. Cell Biochem Funct 28(4):274–277

    Article  PubMed  Google Scholar 

  24. Crilly A, Hamilton J, Clark CJ et al (2002) Analysis of transforming growth factor beta 1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis 61(8):678–681

    Article  CAS  PubMed  Google Scholar 

  25. Lee EB, Kim JY, Lee YJ et al (2004) Transforming growth factor-beta 1 polymorphisms in Korean patients with systemic sclerosis. Tissue Antiqens 63(5):491–495

    Article  CAS  Google Scholar 

  26. Ohtsuka T, Yamakage A, Yamazaki S (2002) The polymorphism of transforming growth factor-β1 gene in Japanese patients with systemic sclerosis. Br J Dermatol 147(3):458–463

    Article  CAS  PubMed  Google Scholar 

  27. Suqiura Y, Banno S, Matsumoto Y et al (2003) Transforming growth factor beta 1 gene polymorphism in patients with systemic sclerosis. J Rheumatol 30(7):1520–1523

    Google Scholar 

  28. Zhou X, Tan FK, Stivers DN et al (2000) Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association. Arthritis Rheum 43(5):1068–1073

    Article  CAS  PubMed  Google Scholar 

  29. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129

    Article  Google Scholar 

  30. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

    Article  PubMed  Google Scholar 

  31. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  CAS  PubMed  Google Scholar 

  32. Egger M, Davey SG, Schneider M et al (1997) Bias inmeta-analysis detected by a simple, graphical test. Br Med J 315:629–634

    Article  CAS  Google Scholar 

  33. Grainger DJ, Mosedale DE, Metcalfe JC (2000) TGF-beta in blood: a complex problem. Cytokine Growth Factor Rev 11(1–2):133–145

    Article  CAS  PubMed  Google Scholar 

  34. Grainger DJ, Heathcote K, Chiano M et al (1999) Genetic control of the circulating concentration of transforming growth factor type beta 1. Hum Mol Genet 8(1):93–97

    Article  CAS  PubMed  Google Scholar 

  35. Kehrl JH (1991) Transforming growth factor-beta: an important mediator of immunoregulation. Int J Cell Cloning 9:438–450

    Article  CAS  PubMed  Google Scholar 

  36. Dang H, Geiser AG, Letterio JJ et al (1995) SLE-like autoantibodies and sjogren’s syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol 155:3205–3212

    CAS  PubMed  Google Scholar 

  37. Trikalinos TA, Salanti G, Khoury MJ et al (2006) Impact of violations and deviations in Hardy–Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 163:300–309

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was partly supported by the Natural Science Foundation of Anhui Province (1308085MH169), the Key Project of the Education Department of Anhui Province Natural Science Research (KJ2012A165), Annual Plan Aid Fund of Anhui Provincial Finance Department, and Medical Research Fund of Anhui Provincial Health Department (2010C103).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jing Wang.

Additional information

Li Zhang and Jun-wei Yan contributed equally to this work, and co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, L., Yan, Jw., Wang, YX. et al. Association of TGF-β1 +869C/T promoter polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Mol Biol Rep 40, 4811–4817 (2013). https://doi.org/10.1007/s11033-013-2577-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-013-2577-4

Keywords

Navigation